Pfizer board member says COVID will be over in the US sooner than you think
After almost two years, the end of the COVID-19 pandemic is finally at hand in the US. That’s according to former FDA commissioner and Pfizer …
After almost two years, the end of the COVID-19 pandemic is finally at hand in the US. That’s according to former FDA commissioner and Pfizer …
As more contagious COVID variants spread across the US, Pfizer is exploring the utility of a third booster dose. Pfizer hopes that a third vaccine …
A study that included 1.2 million people in Israel, half of which were fully vaccinated with the Pfizer/BioNTech drug, shows the vaccine is highly effective …
Pfizer and BioNTech announced a significant change to their coronavirus vaccine that could have a dramatic impact on shipping logistics and vaccine availability. The two …
Pfizer says that coronavirus vaccine output will be greatly improved as the company has increased manufacturing efficiency. The company has reduced the time it takes …
Pfizer is planning to deliver 200 million COVID vaccine doses to the US by May. Pfizer has managed to ramp up vaccine production significantly in …
A study from Israel indicates that people who received the Pfizer/BioNTech coronavirus vaccine develop an immune response significantly stronger than COVID-19 survivors. These researchers think …
Pfizer and BioNTech announced they completed testing that shows the key mutation present on the UK and South African coronavirus strains would not create resistance …
Two of the novel coronavirus vaccine frontrunners have reported incredible interim efficacy data, with both Pfizer and Moderna saying their drugs work in more than …
The Pfizer coronavirus vaccine is even more effective than experts had hoped, according to interim data released earlier this week. Figures may change, but Pfizer …
HHS Secretary Alex Azar has given a rough outline regarding how and when the Pfizer vaccine to fight COVID-19 will start being distributed. In an …
Pfizer CEO Dr. Albert Bourla said in an interview there are “no safety concerns” for the BioNTech coronavirus vaccine that has shown effecacy of 90%, …
The first interim results for one of the leading coronavirus vaccine candidates have arrived, showing incredibly promising efficacy results. According to the first batch of …
The UK has accelerated the review of the three coronavirus vaccine frontrunners: AstraZeneca, Moderna, and Pfizer. The country’s government is conducting rolling reviews, which allow …
Coronavirus vaccine candidate maker Pfizer was expected to release early efficacy results for Phase 3 in mid-October, ahead of the presidential election. That’s no longer …
The company making the only coronavirus vaccine with a theoretical chance of being approved before the US presidential election made it clear such a timeline …
The only coronavirus vaccine candidate that still has a chance of being approved for emergency use by election day is being fast-tracked in Europe as …
One of the most promising novel coronavirus vaccine candidates might complete the Phase 3 stage of clinical trials as soon as next month, and the …
In a significant coronavirus vaccine update, Pfizer and BioNTech announced additional details about their experimental drug that has just started Phase 2/3 testing. The two …
A second coronavirus vaccine trial has entered the final stage of testing, and the research could be finalized as soon as October. One of the …
The latest coronavirus vaccine development update comes from the US government, which inked a new deal for a promising vaccine made by BioNTech and Pfizer. …
Coronavirus vaccine research is moving along well, with another candidate showing promising results at preventing the COVID-19 infection. Pfizer’s CEO Albert Bourla said in an …
Another coronavirus vaccine candidate has shown promising results in a Phase 1/2 trial conducted in the US. An mRNA experimental drug made by BioNTech, which …
Another potential coronavirus vaccine might be available this fall. Pfizer said the candidate it’s developing with BioNTech could be ready by October if everything goes …
German biopharmaceutical company BioNTech partnered with Pfizer on the development of an mRNA vaccine for the novel coronavirus. Their product reached the clinical phase trial …
A new coronavirus vaccine candidate from Germany has entered human trials, and it might be ready for emergency use as soon as this fall. Vaccine …
Pfizer has a promising drug in development that targets the novel coronavirus’s ability to replicate. The new drug could help save patients experiencing mild-to-moderate COVID-19 …